Occupational Therapy Assistant (OTA.S.AAS)
- Division: Health Sciences
- Department: Rehabilitation Services
Occupational therapy assistants, under the supervision of occupational therapists, provide services to individuals whose abilities to cope with daily tasks are threatened or impaired by developmental deficits, aging, injury or illness. They help people prevent, lessen, or overcome physical, cognitive and/or psychosocial dysfunction so that they are able to function with maximum independence. The program includes extensive clinical training that must be finished within 12 months of completion of the academic course work. A grade of "C" or higher (77%) is required in all program courses to remain in the program. The Occupational Therapy Assistant program is designed to be completed in five (5) semesters on a full-time basis, when the student begins the technical portion of the program. This degree program consists of open enrollment courses (general education and division specific) and program specific courses with limited enrollment. The open enrollment courses may be taken prior to entry into the limited enrollment courses (OTA specific courses). To qualify for entry to limited enrollment courses, please see the OTA Program Specific Information Packet (PDF) below under Additional Information. Note: For students under age 18 there may be restrictions on participating in certain Health Sciences programs. Any student under age 18 must contact the program director/department chair to discuss whether he or she may enroll.
The Occupational Therapy Assistant program is accredited by the Accreditation Council for Occupational Therapy Education (ACOTE) of the American Occupational Therapy Association (AOTA), located at ACOTE c/o AOTA, 6116 Executive Boulevard, Suite 200, North Bethesda, MD 20852-4929. AOTA's telephone number is (301) 652-2682. www.acoteonline.org/ The program received a 7-year reaccreditation term in 2013. It is scheduled to be reaccredited in 2021/2022 (The 2020/2021 site visit was delayed due to COVID-19).